Development of potential anticancer agents that target the telomere sequence

被引:8
|
作者
Park, Myunji [1 ]
Bruice, Thomas C. [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA
关键词
Telomere; Telomerase; Cancer; DEOXYNUCLEIC GUANIDINE DNG; SOLID-PHASE SYNTHESIS; DEOXYRIBONUCLEIC GUANIDINE; BINDING; LINKAGES; FIDELITY; RNA; HOMOPOLYNUCLEOTIDES; OLIGONUCLEOTIDES; CHROMOSOMES;
D O I
10.1016/j.bmcl.2010.04.089
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The immortality of cancer cells is due to the relatively high concentration of telomerase enzyme that maintains the telomere sequence during cell division. Human telomeric DNA consists of repeats of the sequence d(5'-TTAGGG-3'). Deoxyribonucleic guanidine ( DNG) is a DNA analog in which positively charged guanidine [-NH-C(=NH2+)-NH-] replaces the negatively charged phosphodiester of DNA. The synthesized DNG hexamer AgAgTgCgCpC and dodecamer AgAgTgCgCgCAgAgTgCgCpC are complementary to the non-coding telomere sequence d(5'-TTAGGG-3'). We have found that binding of the complementary DNG hexamer to the telomere is favored over that of DNA telomere by 10(2.5)-fold and binding the dodecamer with 2-mismatched DNA is favored by 10(5)-fold. We have shown that DNG binding to RNA is favored over binding to DNA. A complementary complex of DNG with RNA at the active site of telomerase enzyme would be very stable. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3982 / 3986
页数:5
相关论文
共 50 条
  • [31] Shikimate kinase: A potential target for development of novel antitubercular agents
    Pereira, Jose H.
    Vasconcelos, Igor B.
    Oliveira, Jaim S.
    Caceres, Rafael A.
    de Azevedo, Walter F., Jr.
    Basso, Luis A.
    Santos, Diogenes S.
    CURRENT DRUG TARGETS, 2007, 8 (03) : 459 - 468
  • [32] The methodology of the development of anticancer agents
    Connors, TA
    BALKAN CONGRESS OF ONCOLOGY, 1996, : 15 - 20
  • [33] CELL-MEMBRANES AS TARGET FOR ANTICANCER AGENTS
    ARANCIA, G
    DONELLI, G
    PHARMACOLOGICAL RESEARCH, 1991, 24 (03) : 205 - 217
  • [34] The Progress of the Anticancer Agents Related to the Microtubules Target
    Olatunde, Olagoke Zacchaeus
    Yong, Jianping
    Lu, Canzhong
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (20) : 2165 - 2192
  • [35] Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents
    Salerno, Silvia
    Barresi, Elisabetta
    Baglini, Emma
    Poggetti, Valeria
    Da Settimo, Federico
    Taliani, Sabrina
    MOLECULES, 2023, 28 (06):
  • [36] Pregnenolone derivatives as potential anticancer agents
    Choudhary, M. Iqbal
    Alam, M. Shahab
    Atta-ur-Rahman
    Yousuf, Sammer
    Wu, Yang-Chang
    Lin, An-Shen
    Shaheen, F.
    STEROIDS, 2011, 76 (14) : 1554 - 1559
  • [37] MEROCYANINES - POTENTIAL NEW ANTICANCER AGENTS
    GRUDA, I
    PAGE, M
    BOLDUC, F
    LALIBERTE, S
    NOEL, C
    ANTICANCER RESEARCH, 1987, 7 (06) : 1125 - 1127
  • [38] GLYOXALASE INHIBITORS AS POTENTIAL ANTICANCER AGENTS
    VINCE, R
    WADD, WB
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1969, 35 (05) : 593 - &
  • [39] Selective Acetogenins and Their Potential as Anticancer Agents
    Jacobo-Herrera, Nadia
    Perez-Plasencia, Carlos
    Alberto Castro-Torres, Victor
    Martinez-Vazquez, Mariano
    Rosa Gonzalez-Esquinca, Alma
    Zentella-Dehesa, Alejandro
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [40] Platinum complexes as potential anticancer agents
    Khan, Rais Ahmad
    Alsalme, Ali
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256